Equities
  • Price (HKD)2.67
  • Today's Change0.12 / 4.71%
  • Shares traded49.52m
  • 1 Year change-3.26%
  • Beta--
Data delayed at least 15 minutes, as of Feb 06 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The Company operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.

  • Revenue in HKD (TTM)3.24bn
  • Net income in HKD-26.65m
  • Incorporated2021
  • Employees485.00
  • Location
    Fangzhou IncFloor 1-2, 4th Street, Building SKehui Jingu, No. 99, Science Avenue, LuGUANGZHOU ChinaCHN
  • Websitehttps://investors.jianke.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.